PJ Online | News: MHRA alert: Pan Pharmaceuticals

Home > PJ (current issue) > News / Daily News | Search

The Pharmaceutical Journal
Vol 270 No 7251 p740
31 May 2003

Related websites
MHRA Pan Pharmaceuticals recall notice (PDF 115K)
MHRA: Product recall information update (PDF 135K) 6 June 2003

Australian Therapeutic Goods Administration
Urgent Medicine Recall — Products manufactured by Pan Pharmaceuticals Limited and supplied by various sponsors and distributors (more)

UPDATE — 6 June 2003
The Medicines and Healthcare products Regulatory Agency stated below that Health Perception had bought products from suspended Australian manufacturer Pan Pharmaceuticals (PJ, 31 May, p740). The MHRA now confirms that this is not correct for the period affected by the current global product recall
MHRA: Product recall information update (PDF 135K)

MHRA alert: Pan Pharmaceuticals

The Medicines and Healthcare products Regulatory Agency has issued a warning that Pan Pharmaceuticals Pty Ltd, Australia, has had its manufacturing authorisation suspended by the Australian Therapeutic Goods Administration because of serious safety and quality breaches. These include substitution of ingredients, manipulation of test results and substandard manufacturing processes.

Pan Pharmaceuticals produced a wide range of medicines, herbal products and nutritional and vitamin supplements marketed under its own name and on behalf of other companies. Nearly 2,000 products, mostly intended for export, are affected. British companies known to have imported products manufactured by Pan include Health Imports, Illingworth & Illingworth Health Foods, Health Perceptions and Synpharma. Details of products known to have been affected are here.

* PDF files on PJ Online require Acrobat Reader 4 or later